HIV and the lung in the HAART era

AIDS Reader

Volumn 15, Issue 7, 2005, Pages

  Laurence, Jeffrey ^a,b,c  

^a Department of Medicine ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c American Foundation for AIDS Research (amfAR)   (United States)

Author keywords

Emphysema; HAART; HIV AIDS; Lung cancer; Lymphocytic interstitial pneumonitis; Primary pulmonary hypertension; Smoking

Indexed keywords

ANTIRETROVIRUS AGENT;

EDITORIAL; EMPHYSEMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG CANCER; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION; SMOKING;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; PULMONARY EMPHYSEMA; RISK FACTORS; SMOKING;

EID: 22144443227     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Laurence J. HPV-linked malignancy and the potential of vaccine-based prevention. AIDS Reader. 2005;15:3-4.
2. Phelps RM, Smith DK, Heilig CM, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer. 2001;94:753-757.
3. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000;92:1823-1830.
4. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004;39:1380-1384.
5. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
6. Allardice GM, Hold DJ, Brewster DH, et al. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer. 2003;89:505-507.
7. Spano JP, Massiani MA, Bentata M, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol. 2004;21:109-115.
8. Patel P, Novak RM, Tong T, et al. Incidence of non-AIDS-defining malignancies in the HIV Outpatient Study. Presented at the 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco. Abstract 81.
9. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr. 1999;21(suppl 1):S5-S10.
10. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
11. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132:369-372.
12. +ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:711-717.
13. Shapiro SD. COPD unwound. N Engl J Med. 2005;352:2016-2019.
14. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352:1967-1976.
15. Miguez-Burbano MJ, Burbano X, Ashkin D, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;8:39-43.
16. Dufour V, Wislez M, Bergot E, et al. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003;36:e127-130.
17. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest. 2000;118:1133-1141.
18. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology. 2001;52:31-41.